Group One Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-601
Closed -$2K 6845
2020
Q2
$2K Hold
601
﹤0.01% 5611
2020
Q1
$1K Buy
601
+110
+22% +$224 ﹤0.01% 5160
2019
Q4
$1K Hold
491
﹤0.01% 5033
2019
Q3
$3K Sell
491
-395
-45% -$2.63K ﹤0.01% 4892
2019
Q2
$9K Buy
886
+525
+145% +$9.66K ﹤0.01% 4471
2019
Q1
$10K Buy
+361
New +$9.19K ﹤0.01% 4290
2018
Q4
Sell
-1
Closed -$39 5716
2018
Q3
$0 Sell
1
-4,506
-100% -$288K ﹤0.01% 5842
2018
Q2
$322K Buy
4,507
+3,735
+484% +$264K ﹤0.01% 2661
2018
Q1
$47K Sell
772
-2,737
-78% -$240K ﹤0.01% 3700
2017
Q4
$442K Sell
3,509
-2,559
-42% -$328K ﹤0.01% 2348
2017
Q3
$830K Buy
+6,068
New +$812K 0.01% 1700
2017
Q2
Sell
-1,063
Closed -$164K 5298
2017
Q1
$195K Buy
1,063
+1,012
+1,984% +$113K ﹤0.01% 2545
2016
Q4
$4K Sell
51
-1,545
-97% -$122K ﹤0.01% 4168
2016
Q3
$122K Sell
1,596
-1,418
-47% -$114K ﹤0.01% 2818
2016
Q2
$259K Sell
3,014
-728
-19% -$66.7K ﹤0.01% 2228
2016
Q1
$347K Buy
3,742
+1,368
+58% +$137K ﹤0.01% 1959
2015
Q4
$476K Buy
+2,374
New +$474K 0.01% 1850
2015
Q3
Sell
-985
Closed -$723K 5386
2015
Q2
$934K Buy
985
+526
+115% +$430K 0.01% 1264
2015
Q1
$336K Buy
459
+191
+71% +$143K 0.01% 1936
2014
Q4
$213K Buy
+268
New +$144K ﹤0.01% 2264
2014
Q3
Sell
-555
Closed -$149K 5597
2014
Q2
$150K Buy
555
+57
+11% +$12.2K ﹤0.01% 2640
2014
Q1
$108K Buy
+498
New +$139K ﹤0.01% 3009

Group One Trading's TTPH Position: Q3 2020 in Review

Group One Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 601 shares — an estimated $2K sold.

Group One Trading first reported a position in TTPH in Q1 2014 and held it in 22 quarters. The position peaked at $934K in Q2 2015. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

  • Group One Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Group One Trading sold 601 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2K.
  • Group One Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2014 and held it in 22 quarters.
  • Group One Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $934K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on Group One Trading's 13F filing for Q3 2020, filed 12 Nov 2020.